Roivant Sciences Ltd. filed a Form 8-K on September 18, 2026, reporting the final voting results from its 2026 Annual General Meeting of Shareholders held on September 16, 2026.

Key Highlights

  • Quorum reached: Holders of 652,143,869 common shares, representing approximately 90.3% of the 722,406,273 shares entitled to vote, were present in person or by proxy.
  • Director re-election: Daniel Gold received 375,791,264 votes for and 210,203,958 withheld; Meghan FitzGerald received 422,428,908 votes for and 163,566,314 withheld.
  • Auditor ratified: Ernst and Young LLP was ratified as independent registered public accounting firm for the fiscal year ending March 31, 2027, with 651,315,490 votes for and 731,364 against.
  • Executive pay approved: The non-binding advisory vote on named executive officer compensation passed with 316,702,500 votes for and 269,062,122 against.
  • All proposals approved: According to the filing, all proposals on the agenda were approved by the shareholders.

Roivant Sciences 2026 Annual General Meeting: Director Elections, Auditor, and Executive Pay Vote Details

Roivant Sciences Ltd. (NASDAQ:ROIV) disclosed the results of its 2026 Annual General Meeting of Shareholders, held on September 16, 2026, via a Form 8-K filed with the SEC on September 18, 2026. The company reported that shareholders considered and acted upon three proposals, each of which was approved, as described in the company's proxy statement filed with the SEC on July 29, 2026. The record date for the meeting was July 23, 2026.

Under Proposal 1, shareholders re-elected two Class II directors to serve until the annual general meeting following the fiscal year ending March 31, 2029. Daniel Gold received 375,791,264 votes for and 210,203,958 withheld, with 66,148,647 broker non-votes. Meghan FitzGerald received 422,428,908 votes for and 163,566,314 withheld, with the same 66,148,647 broker non-votes. The filing noted that election required approval by a plurality of the votes cast.

Proposal 2 sought ratification of Ernst and Young LLP as the company's independent registered public accounting firm and as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for the fiscal year ending March 31, 2027. The vote was 651,315,490 for, 731,364 against, and 97,015 abstentions, with no broker non-votes recorded. Proposal 3, a non-binding advisory vote on named executive officer compensation as disclosed in the proxy statement, passed with 316,702,500 votes for, 269,062,122 against, 230,600 abstentions, and 66,148,647 broker non-votes. Both proposals required the affirmative vote of a majority of votes cast, according to the filing.

What Was Disclosed

The filing reported final shareholder vote counts for three proposals at Roivant Sciences' 2026 Annual General Meeting: the re-election of two Class II directors, ratification of Ernst and Young LLP as auditor, and a non-binding advisory vote on executive compensation. All three proposals passed.